As shown in figure 6C, treatment of BCR-ABL+ cells with 40 μM α-bisabolol for 24 hours resulted in a strong decrease in the oxygen consumption in presence of FCCP (uncoupled respiration) (786±187 vs 2403±244, 423±41 vs 1622±240 and 974±91 vs 1608±234 pmol O2•min−1/106 cells for K562, LAMA-84 and CML-T1 respectively, p<.05). The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.